US FDA issues guidance on apps used with prescription drugs

FDA finalizes its guidance on apps related to drugs, pharma rejoices

In this edition of STAT Health Tech: The FDA's final guidance on prescription drug use-related software, and telehealth pushing off-label use of GLP-1s for addiction.

Companion Apps for Prescription Drugs Face New FDA Labeling Guidance Meant to Keep Patient Medication Information Accurate

FDA finalized guidance on apps paired with prescription drugs, from inhaler trackers to dose reminders. Here is what it means for patients.

US FDA issues guidance on apps used with prescription drugs - Regional Media News

Oct 20 (Reuters) - The US FDA on Tuesday issued guidance aimed at clarifying how drug companies can develop, distribute and label apps used alongside their prescription medicines. Here are some details: • The policy outlines when content in such apps must be submitted to [...]

US FDA issues guidance on apps used with prescription drugs

Oct 20 (Reuters) – The US FDA on Tuesday issued guidance aimed at clarifying how drug companies can develop, ​distribute and label apps used ‌alongside their prescription medicines. Here are some details: • The policy outlines when content in such apps must be submitted to the US Food and ‌Drug ​Administration, when those apps ⁠should be referenced ⁠in a drug’s prescribing information, and what information companies need to provide to the health…

FDA Releases Final Guidance for Prescription Drug-Related Apps

Open the article to view the coverage from The Well News | Pragmatic, Governance, Fiscally Responsible, News & Analysis